Pharmosa Biopharm Balance Sheet Health
Financial Health criteria checks 4/6
Pharmosa Biopharm has a total shareholder equity of NT$1.1B and total debt of NT$2.4M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are NT$1.3B and NT$196.0M respectively.
Key information
0.2%
Debt to equity ratio
NT$2.45m
Debt
Interest coverage ratio | n/a |
Cash | NT$974.06m |
Equity | NT$1.14b |
Total liabilities | NT$195.99m |
Total assets | NT$1.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6875's short term assets (NT$1.0B) exceed its short term liabilities (NT$77.6M).
Long Term Liabilities: 6875's short term assets (NT$1.0B) exceed its long term liabilities (NT$118.4M).
Debt to Equity History and Analysis
Debt Level: 6875 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 6875's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 6875's debt is well covered by operating cash flow (1732.9%).
Interest Coverage: Insufficient data to determine if 6875's interest payments on its debt are well covered by EBIT.